Navigation Links
Universal Health Services, Inc. Announces Daniel B. Silvers Appointed to Board of Directors
Date:7/8/2009

KING OF PRUSSIA, Pa., July 8 /PRNewswire-FirstCall/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Daniel B. Silvers has been appointed to its Board of Directors. He becomes the eighth member of the Board of Directors.

Mr. Silvers is currently President of Hayground Cove Capital Partners LLC, in New York, NY, a merchant bank focused on real estate and other industries. Prior to that, Mr. Silvers was a Vice President at Fortress Investment Group LLC in New York, NY, and an Officer at Bear, Stearns & Co. Inc. He earned a B.S. in Economics and an M.B.A. in Finance from The Wharton School, University of Pennsylvania.

Alan B. Miller, Chief Executive Officer and Chairman of the Board of UHS said "Dan Silvers' varied experience in business and finance will enable him to make a valuable contribution to the Board."

Universal Health Services, Inc. is one of the nation's largest hospital companies, operating, through its subsidiaries, acute care and behavioral health hospitals, and ambulatory centers nationwide and in Puerto Rico.

For additional information on the Company, visit our website;

http://www.uhsinc.com.


'/>"/>
SOURCE Universal Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism, Freedom of Choice, Freedom of Practice and Universal Access for Patients
2. John Hancock Launches Current Assumption Universal Life Policy
3. Universal Health Services, Inc. Announces Marc D. Miller Named President of Universal Health Services
4. Universal Health Services, Inc. Announces Dividend
5. Universal CRT Replacement Gives New Life to Medical Equipment with Analog Video
6. Universal Benefit Plans President and CEO Edan Barshan Featured in Altus Dental Annual Report
7. Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL
8. NBC Universal Makes an Unprecedented Commitment to Health and Wellness
9. New universal breast cancer marker predicts recurrence and clinical outcome
10. Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share
11. Universal Health Realty Income Trust Adds New Member to Board of Trustees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... NJ (PRWEB) , ... January 18, 2017 , ... ... care communications company, launched a new website for its Center for Biosimilars, announced ... will include the latest developments in the field of biosimilars through thought leader ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress ... dentists to choose the best drug option for each patient. Dentists have several general ... better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Iowa , Jan. 18, 2017   ... that subsidiary Caretta Therapeutics plans, in the second ... Venodol, a topical roll-on intended to provide relief ... opioid and steroidal analgesics. It was developed under ... to commercialize products derived from snake venom. ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... Jan. 17, 2017  With an annual growth ranging from 6% to 10%, ... SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the ... CPhI SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
Breaking Medicine Technology: